Skip to main content
. 2019 May 18;17(5):298. doi: 10.3390/md17050298

Figure 5.

Figure 5

The significantly differential metabolites relatively upregulated in the drying stage or both the rewetting and drying stages. * significant difference (p-value < 0.05), as compared to the S1 stage. 1—2-Ethylacrylylcarnitine; 2—PC(O-12:0/O-1:0); 3—Dihydroskullcap flavone I; 4—Neuraminic acid; 5—(E)-Resveratrol 3-glucoside 4’-sulfate; 6—Echinenone/ (Myxoxanthin); 7—PE-Cer(d14:2(4E,6E)/24:1(15Z)(2OH)); 8—(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-[glucosyl-(1->4)-b-D-glucoside]; 9—Fenothiocarb; 10—6-Methoxy-9H-carbazole-3-carboxaldehyde; 11—Levomethadyl acetate; 12—3-Indolebutyric acid; 13—CerP(d18:1/12:0); 14—PI(O-16:0/12:0); 15—PC(15:0/19:3(9Z,12Z,15Z))[U]; 16—Taxiphyllin; 17—PG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)); 18—Phosphohydroxypyruvic acid.